Pharmaceuticals
CROMSOURCE Consolidates Its Hybrid Services Model
VERONA, Italy, Sept. 12, 2019 /PRNewswire/ -- CROMSOURCE, an international contract research organization (CRO), has announced consolidation of its Hybrid Services Model. Due to client demand, CROMSOURCE has further refined its Hybrid Services to be able to provide its pharmaceutical, medical de...
2019-09-12 22:18
3389
Menarini: Elcin Barker Ergun Group CEO
FLORENCE, Italy, Sept. 12, 2019 /PRNewswire/ -- The Board of Directors has appointed Mrs.Elcin Barker Ergun as CEO of Menarini Group. "Elcin Barker Ergun is the ideal addition to the Menarini team, in order to continue the agenda of growth in geography and therapeutic areas," commented Eric C...
2019-09-12 20:38
3825
Strekin AG Announces Completion of Patient Recruitment in the RESTORE Phase 3 Clinical Study of STR001
BASEL, Switzerland, Sept. 12, 2019 /PRNewswire/ -- Strekin AG (www.strekin.com
2019-09-12 14:15
2838
Gracell Announces Interim Readout of Investigation for First-in-class FasT CAR-19 in patients with Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia and Extension in Use of FasT CAR to Other Immune Cell Programs
SUZHOU and SHANGHAI, China, Sept. 11, 2019 /PRNewswire/ -- Gracell Biotechnologies Co., Ltd. ("Gracell"), a clinical-stage immune cell therapy company, today announced a positive continued clinical readout of a multi-center pilot study designed to evaluate the safety and efficacy of Gracell's f...
2019-09-12 05:00
2371
Gracell Announces Interim Readout of Investigation for First-in-class FasT CAR-19 in patients with Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia and Extension in Use of FasT CAR to Other Immune Cell Programs
SUZHOU and SHANGHAI, China, Sept. 12, 2019 /PRNewswire/ -- Gracell Biotechnologies Co., Ltd. ("Gracell"), a clinical-stage immune cell therapy company, today announced a positive continued clinical readout of a multi-center pilot study designed to evaluate the safety and efficacy of Gracell's f...
2019-09-12 05:00
4549
China Pharma Holdings, Inc. Has Entered into A Memorandum of Understanding With World Health Advanced Technologies, Ltd.
HAIKOU CITY, China, Sept. 11, 2019 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," "CPHI", the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced that it has entered...
2019-09-11 20:00
7199
China SXT Pharmaceuticals, Inc. Granted to Establish Taizhou Research Center for Advanced TCMP Engineering Techniques
TAIZHOU, China, Sept. 11, 2019 /PRNewswire/ -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces ("TCMPs"), including A...
2019-09-11 19:00
7566
Merck Announces FDA Breakthrough Therapy Designation for Investigational Therapy Tepotinib in Patients with Metastatic NSCLC with METex14 Skipping Alterations
DARMSTADT, Germany, Sept. 11, 2019 /PRNewswire/ -- Merck, a leading science and technology company, today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for the investigational targeted therapy tepotinib* in patients with metastatic non-small...
2019-09-11 14:30
2666
Internationally awarded German med-tech innovation by Syntellix now produced in Singapore for the whole of Asia
SINGAPORE, Sept. 10, 2019 /PRNewswire/ -- In the presence of the German Ambassador and the Chairman of EDB Singapore, Syntellix Asia Pte Ltd inaugurates its production site in Tuas, which hosts the first dry CNC processing of such advanced magnesium alloys inAsia. Thus, Singapore becomes the Asi...
2019-09-10 22:14
3051
Blood Cancer Experts Discuss Latest Treatment Innovations at NCCN 2019 Annual Congress: Hematologic Malignancies™
Program includes debate and interactive case studies on emerging cancer care practices.#NCCNhem19. SAN FRANCISCO, Sept. 10, 2019 /PRNewswire/ -- World-renowned experts on blood cancers are meeting inSan Francisco on September 27-28, to help clinicians stay up-to-date on new, practice-changing st...
2019-09-10 20:35
1931
Insilico Medicine Secures $37M in Series B Funding Led by Qiming Venture Partners
HONG KONG, Sept. 10, 2019 /PRNewswire/ -- Insilico Medicine, a pioneer in next-generation artificial intelligence technology for drug discovery, recently completes a$37 million funding round led by Qiming Venture Partners, joined by Eight Roads, F-Prime Capital, Lilly Asia Ventures, Sinovation Ve...
2019-09-10 09:00
4509
Updated Results for Investigational Therapy Tepotinib Presented at WCLC 2019
* Results include progression-free survival and overall survival data from Phase Ib/II INSIGHT study * Phase II INSIGHT 2 study now open for enrollment for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) mutation and...
2019-09-09 20:00
2967
Clarivate Analytics acquires the SequenceBase business to expand its search and analysis capabilities for the life sciences IP market
Derwent, a Clarivate Analytics company and world-leading IP intelligence provider, to offer sequence searching for the fast-growing biologics market. LONDON and PHILADELPHIA, Sept. 9, 2019 /PRNewswire/ -- Clarivate Analytics plc (NYSE:CCC;CCC.WS), a global leader in providing trusted insights and...
2019-09-09 19:00
13708
SpePharm AG Wins Case Against Eisai Inc. in United States District Court for District of Delaware
AMSTERDAM, Sept. 9, 2019 /PRNewswire/ -- SpePharm AG, a subsidiary of Norgine B.V., announced thatthe United States District Court for the District of Delaware ruled on 4th September 2019 in favour of SpePharm in its proceeding against Eisai Inc., upholding SpePharm's licensed rights for SALAGEN®...
2019-09-09 15:00
1155
IASLC World Conference on Lung Cancer--Press Briefing Summary from Sunday, September 8th
Note: This is a summary of research presented this morning at the International Association for the Study of Lung Cancer's World Conference on Lung Cancer. You may also view the recording of the press briefing at: https://wclc2019.iaslc.org/live-press-conference/. Phase One Study Shows Novel K...
2019-09-09 10:10
834
HCmed Innovations joins Wuxi International Life Science Innovation Park supported by AstraZeneca China
TAIPEI, Sept. 7, 2019 /PRNewswire/ -- Supported by the idea of garnering global wisdom to improve the healthcare system inChina, Wuxi Municipal Government, Wuxi High-tech District, and AstraZeneca, as a founding partner, officially inaugurated Wuxi International Life Science Innovation Park onSep...
2019-09-07 18:30
2171
Takeda Issues US Recall of NATPARA® (parathyroid hormone) for Injection Due to the Potential for Rubber Particulate
Patients are advised to immediately consult their healthcare providers to help ensure safe discontinuation of NATPARA treatment Takeda is working closely with the US Food and Drug Administration (US FDA) to resolve the issue and resume supply as soon as possible OSAKA, Japan, Sept. 6, 2019 /PRNe...
2019-09-06 05:59
7911
CMAB Biopharma Receives Positive Opinion Following External Quality Audit
* CMAB Biopharma today reports a positive opinion from a recent QP audit conducted by Parexel International Co. * CMAB's fully integrated CDMO facility in Suzhou, China was found to conform to EU Eudralex Vol. 4 Good Manufacturing Practice (GMP) guidelines * This achievement signals CMAB Bio...
2019-09-05 18:41
4371
Bactiguard Recruits Experienced Chief Medical and Technology Officer
STOCKHOLM, Sept. 5, 2019 /PRNewswire/ -- Stefan Grass with extensive clinical experience as a physician and researcher, combined with senior positions in the pharmaceutical industry, has been recruited to a newly established, global role as Chief Medical and Technology Officer. He will assume his...
2019-09-05 14:41
1942
CROMSOURCE Continues US Growth With New Office in Research Triangle Park
CARY, North Carolina, Sept. 4, 2019 /PRNewswire/ -- CROMSOURCE, an international contract research organization (CRO) has just opened a newly expanded office inCary, NC. Due to the growth of CROMSOURCE in the United States over the past few years, this new location serves as a complement to two ...
2019-09-04 21:00
1774
Week's Top Stories
Most Reposted
Troy Animal Healthcare Strengthens Quality Operations with Veeva Vault Quality
[Picked up by 321 media titles]
2024-05-17 07:00Ultima Markets Recognised as Most Popular Broker 2024 by BrokersView
[Picked up by 319 media titles]
2024-05-15 12:00
Home to half of the world's top 10 trending tourism destinations, Asia Pacific is making a comeback: Mastercard Economics Institute on travel in 2024
[Picked up by 303 media titles]
2024-05-16 15:00
US-BASED PANDUIT ELEVATES MANUFACTURING LANDSCAPE WITH NEW STATE-OF-THE-ART PLANT IN JOHOR BAHRU, MALAYSIA
[Picked up by 274 media titles]
2024-05-16 09:39
Trip.com Group and Rezdy Join Forces to Offer New Travel Experiences Around the World
[Picked up by 229 media titles]
2024-05-14 18:07Most Read
Ultima Markets Recognised as Most Popular Broker 2024 by BrokersView
2024-05-15 12:00
9468
Home to half of the world's top 10 trending tourism destinations, Asia Pacific is making a comeback: Mastercard Economics Institute on travel in 2024
2024-05-16 15:00
7775
US-BASED PANDUIT ELEVATES MANUFACTURING LANDSCAPE WITH NEW STATE-OF-THE-ART PLANT IN JOHOR BAHRU, MALAYSIA
2024-05-16 09:39
7379
Casio to Release G-SHOCK-Surfrider Foundation Collaboration
2024-05-15 09:00
7055
Traveloka strengthens sustainability pledge as world's first Platinum Sponsor of GSTC
2024-05-13 16:42
6853
